EGFR and lung carcinoma: In a study of EGFR mutant lung cancer, Nakayama and colleagues (2014) found that ethacrynic acid can reduce lung tumor formation in an in vivo mouse model by inhibiting β-catenin in the Wnt signaling pathway [119].